Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers

Authors

  • Nayereh Khadem Ghaebi Women’s Health Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran
  • Zahra Meshkat Microbiology and Virology Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

Cervical cancer is, globally known to be, one of the most common cancers among women especially indeveloping countries. More than 90% of cervical cancers are associated with high-risk humanpapillomaviruses (HPVs) particularly HPV types 16 and 18. Two major strategies have been developed forprevention and treatment of cervical cancer and other HPV-associated malignancies; the first one is based onHPV virus-like particles (VLPs) containing HPV structural proteins. VLP based vaccines can inducegenotype specific virus neutralizing antibodies for preventing HPV infections. The other strategy is based onHPV early genes especially E6 and E7 for eliminating the established HPV infections; therefore they areclassified as HPV therapeutic vaccines. This article reviews the preventive and therapeutic vaccines againstHPV infections and cervical cancer.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

preventive and therapeutic vaccines against human papillomaviruses associated cervical cancers

cervical cancer is, globally known to be, one of the most common cancers among women especially indeveloping countries. more than 90% of cervical cancers are associated with high-risk humanpapillomaviruses (hpvs) particularly hpv types 16 and 18. two major strategies have been developed forprevention and treatment of cervical cancer and other hpv-associated malignancies; the first one is based ...

full text

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer

Cervical cancer and its precursor intra-epithelial lesions are linked to infection by a subset of so-called "highrisk" human papillomavirus types, which are estimated to infect nearly four hundred million women worldwide. Two prophylactic vaccines have been commercialized recently targeting HPV16 and 18, the most prevalent viral types found in cervical cancer, which operate through induction of...

full text

Human papillomavirus-associated cervical cancer: Prophylactic and therapeutic vaccines

Abbreviations: Adeno-associated virus, (AAV); bacilli Calmette-Guerin, (BCG); base pairs, (bp); cottontail rabbit papilloma virus, (CRPV); E6-associated protein, (E6-AP); epidermal growth factor receptor, (EGFR); histone deacetylases, (HDAC); human papillomavirus, (HPV); inverted terminal repeats, (ITRs); listerolysin O, (LLO); of lysosome-associated membrane protein, (LAMP); open reading frame...

full text

Current and Next-generation Vaccines against Human Papillomaviruses

Human papillomaviruses (HPVs) infect the squamous epithelium, and cause skin warts, genital warts and cancers, including uterine cervical cancer. Amongst the enormously diverse types of HPVs, HPV16 and HPV18 are most prevalent and responsible for approximately 70% of cervical cancer cases. Current preventive HPV vaccines contain virus-like particles which are composed of L1 major capsid protein...

full text

Human papillomaviruses and cervical cancer

The central causal role of the human papillomaviruses (HPV) in cervical cancer has been well established. The association is present in almost all cases of cervical cancer in the world. The ability of HPV oncogenes to interact with host cell cycle and growth regulators, as well as to elude the immune response and protect infected cells from apoptosis, can promote the persistence of the infectio...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 15  issue 1

pages  585- 601

publication date 2012-01-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023